Global Leukemia Molecular Diagnostics Supply, Demand and Key Producers, 2024-2030

Description

Molecular diagnosis of leukemia is a method of diagnosing and classifying leukemia by detecting specific gene mutations, chromosomal abnormalities or other molecular markers in leukemia patients. This diagnostic technology uses advanced molecular biology tools such as PCR (polymerase chain reaction), gene sequencing and fluorescence in situ hybridization (FISH) to identify molecular features in leukemia cells. Molecular diagnosis of leukemia not only helps to diagnose the disease, but also can accurately classify leukemia subtypes, providing an important basis for the formulation of individualized treatment plans. This precise diagnostic method helps to assess the patient's prognosis, monitor the effectiveness of treatment, and detect the risk of recurrence at an early stage. It is an indispensable tool in modern leukemia management.

The global Leukemia Molecular Diagnostics market size is expected to reach $ 3878 million by 2030, rising at a market growth of 10.1% CAGR during the forecast period (2024-2030).

The increasing adoption of personalized medicine is a key driver for the leukemia molecular diagnostics market. Advances in molecular diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), enable precise genetic profiling of leukemia, leading to more targeted and effective treatment plans. This personalized approach not only improves patient outcomes but also boosts demand for molecular diagnostics in leukemia management.

One of the main challenges in the leukemia molecular diagnostics market is the high cost associated with advanced diagnostic tools and testing procedures. These technologies often require significant investment in equipment, skilled personnel, and infrastructure, which can limit accessibility in low-resource settings, reducing the potential reach of molecular diagnostics in leukemia care.

This report studies the global Leukemia Molecular Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Leukemia Molecular Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Leukemia Molecular Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Leukemia Molecular Diagnostics total market, 2019-2030, (USD Million)
Global Leukemia Molecular Diagnostics total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Leukemia Molecular Diagnostics total market, key domestic companies, and share, (USD Million)
Global Leukemia Molecular Diagnostics revenue by player, revenue and market share 2019-2024, (USD Million)
Global Leukemia Molecular Diagnostics total market by Type, CAGR, 2019-2030, (USD Million)
Global Leukemia Molecular Diagnostics total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Leukemia Molecular Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ruiang Gene, Zhishan Bio, Zhijiang Bio, Jinpujia Medical, Merle Bio, Herui Gene, Aicon Bio, Annuouda, Beijing Wantai, Haixi Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Leukemia Molecular Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Leukemia Molecular Diagnostics Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Leukemia Molecular Diagnostics Market, Segmentation by Type
    PCR
    FISH
    DNA Sequencing
    Gene Chip

Global Leukemia Molecular Diagnostics Market, Segmentation by Application:
    Clinical Diagnosis
    Drug Screening
    Research

Companies Profiled:
    Ruiang Gene
    Zhishan Bio
    Zhijiang Bio
    Jinpujia Medical
    Merle Bio
    Herui Gene
    Aicon Bio
    Annuouda
    Beijing Wantai
    Haixi Bio
    Qiagen
    Abbott
    Kanglu Biotechnology
    Guangzhou Anbiping

Key Questions Answered
1. How big is the global Leukemia Molecular Diagnostics market?
2. What is the demand of the global Leukemia Molecular Diagnostics market?
3. What is the year over year growth of the global Leukemia Molecular Diagnostics market?
4. What is the total value of the global Leukemia Molecular Diagnostics market?
5. Who are the Major Players in the global Leukemia Molecular Diagnostics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Leukemia Molecular Diagnostics Introduction
    1.2 World Leukemia Molecular Diagnostics Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Leukemia Molecular Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World Leukemia Molecular Diagnostics Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
        1.3.3 China Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
        1.3.4 Europe Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
        1.3.5 Japan Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
        1.3.6 South Korea Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
        1.3.7 ASEAN Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
        1.3.8 India Based Company Leukemia Molecular Diagnostics Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Leukemia Molecular Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.2 World Leukemia Molecular Diagnostics Consumption Value by Region
        2.2.1 World Leukemia Molecular Diagnostics Consumption Value by Region (2019-2024)
        2.2.2 World Leukemia Molecular Diagnostics Consumption Value Forecast by Region (2025-2030)
    2.3 United States Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.4 China Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.5 Europe Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.6 Japan Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.7 South Korea Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.8 ASEAN Leukemia Molecular Diagnostics Consumption Value (2019-2030)
    2.9 India Leukemia Molecular Diagnostics Consumption Value (2019-2030)

3 World Leukemia Molecular Diagnostics Companies Competitive Analysis
    3.1 World Leukemia Molecular Diagnostics Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Leukemia Molecular Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Leukemia Molecular Diagnostics in 2023
        3.2.3 Global Concentration Ratios (CR8) for Leukemia Molecular Diagnostics in 2023
    3.3 Leukemia Molecular Diagnostics Company Evaluation Quadrant
    3.4 Leukemia Molecular Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 Leukemia Molecular Diagnostics Market: Region Footprint
        3.4.2 Leukemia Molecular Diagnostics Market: Company Product Type Footprint
        3.4.3 Leukemia Molecular Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Leukemia Molecular Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Leukemia Molecular Diagnostics Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Leukemia Molecular Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Leukemia Molecular Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: Leukemia Molecular Diagnostics Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Leukemia Molecular Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Leukemia Molecular Diagnostics Companies and Market Share, 2019-2024
        4.3.1 United States Based Leukemia Molecular Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Leukemia Molecular Diagnostics Revenue, (2019-2024)
    4.4 China Based Companies Leukemia Molecular Diagnostics Revenue and Market Share, 2019-2024
        4.4.1 China Based Leukemia Molecular Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Leukemia Molecular Diagnostics Revenue, (2019-2024)
    4.5 Rest of World Based Leukemia Molecular Diagnostics Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Leukemia Molecular Diagnostics Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Leukemia Molecular Diagnostics Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Leukemia Molecular Diagnostics Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 PCR
        5.2.2 FISH
        5.2.3 DNA Sequencing
        5.2.4 Gene Chip
    5.3 Market Segment by Type
        5.3.1 World Leukemia Molecular Diagnostics Market Size by Type (2019-2024)
        5.3.2 World Leukemia Molecular Diagnostics Market Size by Type (2025-2030)
        5.3.3 World Leukemia Molecular Diagnostics Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Leukemia Molecular Diagnostics Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Clinical Diagnosis
        6.2.2 Drug Screening
        6.2.3 Research
    6.3 Market Segment by Application
        6.3.1 World Leukemia Molecular Diagnostics Market Size by Application (2019-2024)
        6.3.2 World Leukemia Molecular Diagnostics Market Size by Application (2025-2030)
        6.3.3 World Leukemia Molecular Diagnostics Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Ruiang Gene
        7.1.1 Ruiang Gene Details
        7.1.2 Ruiang Gene Major Business
        7.1.3 Ruiang Gene Leukemia Molecular Diagnostics Product and Services
        7.1.4 Ruiang Gene Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Ruiang Gene Recent Developments/Updates
        7.1.6 Ruiang Gene Competitive Strengths & Weaknesses
    7.2 Zhishan Bio
        7.2.1 Zhishan Bio Details
        7.2.2 Zhishan Bio Major Business
        7.2.3 Zhishan Bio Leukemia Molecular Diagnostics Product and Services
        7.2.4 Zhishan Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Zhishan Bio Recent Developments/Updates
        7.2.6 Zhishan Bio Competitive Strengths & Weaknesses
    7.3 Zhijiang Bio
        7.3.1 Zhijiang Bio Details
        7.3.2 Zhijiang Bio Major Business
        7.3.3 Zhijiang Bio Leukemia Molecular Diagnostics Product and Services
        7.3.4 Zhijiang Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Zhijiang Bio Recent Developments/Updates
        7.3.6 Zhijiang Bio Competitive Strengths & Weaknesses
    7.4 Jinpujia Medical
        7.4.1 Jinpujia Medical Details
        7.4.2 Jinpujia Medical Major Business
        7.4.3 Jinpujia Medical Leukemia Molecular Diagnostics Product and Services
        7.4.4 Jinpujia Medical Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Jinpujia Medical Recent Developments/Updates
        7.4.6 Jinpujia Medical Competitive Strengths & Weaknesses
    7.5 Merle Bio
        7.5.1 Merle Bio Details
        7.5.2 Merle Bio Major Business
        7.5.3 Merle Bio Leukemia Molecular Diagnostics Product and Services
        7.5.4 Merle Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Merle Bio Recent Developments/Updates
        7.5.6 Merle Bio Competitive Strengths & Weaknesses
    7.6 Herui Gene
        7.6.1 Herui Gene Details
        7.6.2 Herui Gene Major Business
        7.6.3 Herui Gene Leukemia Molecular Diagnostics Product and Services
        7.6.4 Herui Gene Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Herui Gene Recent Developments/Updates
        7.6.6 Herui Gene Competitive Strengths & Weaknesses
    7.7 Aicon Bio
        7.7.1 Aicon Bio Details
        7.7.2 Aicon Bio Major Business
        7.7.3 Aicon Bio Leukemia Molecular Diagnostics Product and Services
        7.7.4 Aicon Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Aicon Bio Recent Developments/Updates
        7.7.6 Aicon Bio Competitive Strengths & Weaknesses
    7.8 Annuouda
        7.8.1 Annuouda Details
        7.8.2 Annuouda Major Business
        7.8.3 Annuouda Leukemia Molecular Diagnostics Product and Services
        7.8.4 Annuouda Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Annuouda Recent Developments/Updates
        7.8.6 Annuouda Competitive Strengths & Weaknesses
    7.9 Beijing Wantai
        7.9.1 Beijing Wantai Details
        7.9.2 Beijing Wantai Major Business
        7.9.3 Beijing Wantai Leukemia Molecular Diagnostics Product and Services
        7.9.4 Beijing Wantai Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Beijing Wantai Recent Developments/Updates
        7.9.6 Beijing Wantai Competitive Strengths & Weaknesses
    7.10 Haixi Bio
        7.10.1 Haixi Bio Details
        7.10.2 Haixi Bio Major Business
        7.10.3 Haixi Bio Leukemia Molecular Diagnostics Product and Services
        7.10.4 Haixi Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Haixi Bio Recent Developments/Updates
        7.10.6 Haixi Bio Competitive Strengths & Weaknesses
    7.11 Qiagen
        7.11.1 Qiagen Details
        7.11.2 Qiagen Major Business
        7.11.3 Qiagen Leukemia Molecular Diagnostics Product and Services
        7.11.4 Qiagen Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Qiagen Recent Developments/Updates
        7.11.6 Qiagen Competitive Strengths & Weaknesses
    7.12 Abbott
        7.12.1 Abbott Details
        7.12.2 Abbott Major Business
        7.12.3 Abbott Leukemia Molecular Diagnostics Product and Services
        7.12.4 Abbott Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Abbott Recent Developments/Updates
        7.12.6 Abbott Competitive Strengths & Weaknesses
    7.13 Kanglu Biotechnology
        7.13.1 Kanglu Biotechnology Details
        7.13.2 Kanglu Biotechnology Major Business
        7.13.3 Kanglu Biotechnology Leukemia Molecular Diagnostics Product and Services
        7.13.4 Kanglu Biotechnology Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Kanglu Biotechnology Recent Developments/Updates
        7.13.6 Kanglu Biotechnology Competitive Strengths & Weaknesses
    7.14 Guangzhou Anbiping
        7.14.1 Guangzhou Anbiping Details
        7.14.2 Guangzhou Anbiping Major Business
        7.14.3 Guangzhou Anbiping Leukemia Molecular Diagnostics Product and Services
        7.14.4 Guangzhou Anbiping Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Guangzhou Anbiping Recent Developments/Updates
        7.14.6 Guangzhou Anbiping Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Leukemia Molecular Diagnostics Industry Chain
    8.2 Leukemia Molecular Diagnostics Upstream Analysis
    8.3 Leukemia Molecular Diagnostics Midstream Analysis
    8.4 Leukemia Molecular Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Leukemia Molecular Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Leukemia Molecular Diagnostics Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Leukemia Molecular Diagnostics Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Leukemia Molecular Diagnostics Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Leukemia Molecular Diagnostics Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Leukemia Molecular Diagnostics Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Leukemia Molecular Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Leukemia Molecular Diagnostics Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Leukemia Molecular Diagnostics Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Leukemia Molecular Diagnostics Players in 2023
 Table 12. World Leukemia Molecular Diagnostics Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Leukemia Molecular Diagnostics Company Evaluation Quadrant
 Table 14. Head Office of Key Leukemia Molecular Diagnostics Players
 Table 15. Leukemia Molecular Diagnostics Market: Company Product Type Footprint
 Table 16. Leukemia Molecular Diagnostics Market: Company Product Application Footprint
 Table 17. Leukemia Molecular Diagnostics Mergers & Acquisitions Activity
 Table 18. United States VS China Leukemia Molecular Diagnostics Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Leukemia Molecular Diagnostics Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Leukemia Molecular Diagnostics Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Leukemia Molecular Diagnostics Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Leukemia Molecular Diagnostics Revenue Market Share (2019-2024)
 Table 23. China Based Leukemia Molecular Diagnostics Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Leukemia Molecular Diagnostics Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Leukemia Molecular Diagnostics Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Leukemia Molecular Diagnostics Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Leukemia Molecular Diagnostics Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Leukemia Molecular Diagnostics Revenue Market Share (2019-2024)
 Table 29. World Leukemia Molecular Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Leukemia Molecular Diagnostics Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Leukemia Molecular Diagnostics Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Leukemia Molecular Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Leukemia Molecular Diagnostics Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Leukemia Molecular Diagnostics Market Size by Application (2025-2030) & (USD Million)
 Table 35. Ruiang Gene Basic Information, Manufacturing Base and Competitors
 Table 36. Ruiang Gene Major Business
 Table 37. Ruiang Gene Leukemia Molecular Diagnostics Product and Services
 Table 38. Ruiang Gene Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Ruiang Gene Recent Developments/Updates
 Table 40. Ruiang Gene Competitive Strengths & Weaknesses
 Table 41. Zhishan Bio Basic Information, Manufacturing Base and Competitors
 Table 42. Zhishan Bio Major Business
 Table 43. Zhishan Bio Leukemia Molecular Diagnostics Product and Services
 Table 44. Zhishan Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Zhishan Bio Recent Developments/Updates
 Table 46. Zhishan Bio Competitive Strengths & Weaknesses
 Table 47. Zhijiang Bio Basic Information, Manufacturing Base and Competitors
 Table 48. Zhijiang Bio Major Business
 Table 49. Zhijiang Bio Leukemia Molecular Diagnostics Product and Services
 Table 50. Zhijiang Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Zhijiang Bio Recent Developments/Updates
 Table 52. Zhijiang Bio Competitive Strengths & Weaknesses
 Table 53. Jinpujia Medical Basic Information, Manufacturing Base and Competitors
 Table 54. Jinpujia Medical Major Business
 Table 55. Jinpujia Medical Leukemia Molecular Diagnostics Product and Services
 Table 56. Jinpujia Medical Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Jinpujia Medical Recent Developments/Updates
 Table 58. Jinpujia Medical Competitive Strengths & Weaknesses
 Table 59. Merle Bio Basic Information, Manufacturing Base and Competitors
 Table 60. Merle Bio Major Business
 Table 61. Merle Bio Leukemia Molecular Diagnostics Product and Services
 Table 62. Merle Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Merle Bio Recent Developments/Updates
 Table 64. Merle Bio Competitive Strengths & Weaknesses
 Table 65. Herui Gene Basic Information, Manufacturing Base and Competitors
 Table 66. Herui Gene Major Business
 Table 67. Herui Gene Leukemia Molecular Diagnostics Product and Services
 Table 68. Herui Gene Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Herui Gene Recent Developments/Updates
 Table 70. Herui Gene Competitive Strengths & Weaknesses
 Table 71. Aicon Bio Basic Information, Manufacturing Base and Competitors
 Table 72. Aicon Bio Major Business
 Table 73. Aicon Bio Leukemia Molecular Diagnostics Product and Services
 Table 74. Aicon Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Aicon Bio Recent Developments/Updates
 Table 76. Aicon Bio Competitive Strengths & Weaknesses
 Table 77. Annuouda Basic Information, Manufacturing Base and Competitors
 Table 78. Annuouda Major Business
 Table 79. Annuouda Leukemia Molecular Diagnostics Product and Services
 Table 80. Annuouda Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Annuouda Recent Developments/Updates
 Table 82. Annuouda Competitive Strengths & Weaknesses
 Table 83. Beijing Wantai Basic Information, Manufacturing Base and Competitors
 Table 84. Beijing Wantai Major Business
 Table 85. Beijing Wantai Leukemia Molecular Diagnostics Product and Services
 Table 86. Beijing Wantai Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Beijing Wantai Recent Developments/Updates
 Table 88. Beijing Wantai Competitive Strengths & Weaknesses
 Table 89. Haixi Bio Basic Information, Manufacturing Base and Competitors
 Table 90. Haixi Bio Major Business
 Table 91. Haixi Bio Leukemia Molecular Diagnostics Product and Services
 Table 92. Haixi Bio Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Haixi Bio Recent Developments/Updates
 Table 94. Haixi Bio Competitive Strengths & Weaknesses
 Table 95. Qiagen Basic Information, Manufacturing Base and Competitors
 Table 96. Qiagen Major Business
 Table 97. Qiagen Leukemia Molecular Diagnostics Product and Services
 Table 98. Qiagen Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Qiagen Recent Developments/Updates
 Table 100. Qiagen Competitive Strengths & Weaknesses
 Table 101. Abbott Basic Information, Manufacturing Base and Competitors
 Table 102. Abbott Major Business
 Table 103. Abbott Leukemia Molecular Diagnostics Product and Services
 Table 104. Abbott Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Abbott Recent Developments/Updates
 Table 106. Abbott Competitive Strengths & Weaknesses
 Table 107. Kanglu Biotechnology Basic Information, Manufacturing Base and Competitors
 Table 108. Kanglu Biotechnology Major Business
 Table 109. Kanglu Biotechnology Leukemia Molecular Diagnostics Product and Services
 Table 110. Kanglu Biotechnology Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Kanglu Biotechnology Recent Developments/Updates
 Table 112. Kanglu Biotechnology Competitive Strengths & Weaknesses
 Table 113. Guangzhou Anbiping Basic Information, Manufacturing Base and Competitors
 Table 114. Guangzhou Anbiping Major Business
 Table 115. Guangzhou Anbiping Leukemia Molecular Diagnostics Product and Services
 Table 116. Guangzhou Anbiping Leukemia Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Guangzhou Anbiping Recent Developments/Updates
 Table 118. Guangzhou Anbiping Competitive Strengths & Weaknesses
 Table 119. Global Key Players of Leukemia Molecular Diagnostics Upstream (Raw Materials)
 Table 120. Global Leukemia Molecular Diagnostics Typical Customers


List of Figures
 Figure 1. Leukemia Molecular Diagnostics Picture
 Figure 2. World Leukemia Molecular Diagnostics Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Leukemia Molecular Diagnostics Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Leukemia Molecular Diagnostics Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Leukemia Molecular Diagnostics Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Leukemia Molecular Diagnostics Revenue (2019-2030) & (USD Million)
 Figure 13. Leukemia Molecular Diagnostics Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Leukemia Molecular Diagnostics Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Leukemia Molecular Diagnostics Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Leukemia Molecular Diagnostics by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Leukemia Molecular Diagnostics Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Leukemia Molecular Diagnostics Markets in 2023
 Figure 27. United States VS China: Leukemia Molecular Diagnostics Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Leukemia Molecular Diagnostics Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Leukemia Molecular Diagnostics Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Leukemia Molecular Diagnostics Market Size Market Share by Type in 2023
 Figure 31. PCR
 Figure 32. FISH
 Figure 33. DNA Sequencing
 Figure 34. Gene Chip
 Figure 35. World Leukemia Molecular Diagnostics Market Size Market Share by Type (2019-2030)
 Figure 36. World Leukemia Molecular Diagnostics Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World Leukemia Molecular Diagnostics Market Size Market Share by Application in 2023
 Figure 38. Clinical Diagnosis
 Figure 39. Drug Screening
 Figure 40. Research
 Figure 41. World Leukemia Molecular Diagnostics Market Size Market Share by Application (2019-2030)
 Figure 42. Leukemia Molecular Diagnostics Industrial Chain
 Figure 43. Methodology
 Figure 44. Research Process and Data Source

Companies Mentioned

Ruiang Gene
Zhishan Bio
Zhijiang Bio
Jinpujia Medical
Merle Bio
Herui Gene
Aicon Bio
Annuouda
Beijing Wantai
Haixi Bio
Qiagen
Abbott
Kanglu Biotechnology
Guangzhou Anbiping